350 related articles for article (PubMed ID: 24727990)
1. Successes and limitations of targeted therapies in renal cell carcinoma.
Pracht M; Berthold D
Prog Tumor Res; 2014; 41():98-112. PubMed ID: 24727990
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
Bex A; Gore M; Mulders P; Sternberg CN
BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology.
Su D; Singer EA; Srinivasan R
Curr Opin Oncol; 2015 May; 27(3):217-23. PubMed ID: 25811348
[TBL] [Abstract][Full Text] [Related]
4. New perspectives in the treatment of metastatic renal cell carcinoma.
Barrière J; Hoch B; Ferrero JM
Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e16-23. PubMed ID: 22099727
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies.
Costa LJ; Drabkin HA
Oncologist; 2007 Dec; 12(12):1404-15. PubMed ID: 18165617
[TBL] [Abstract][Full Text] [Related]
6. Treatment of metastatic renal cell carcinoma.
Reeves DJ; Liu CY
Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment of renal cell cancer: A comprehensive review.
Sánchez-Gastaldo A; Kempf E; González Del Alba A; Duran I
Cancer Treat Rev; 2017 Nov; 60():77-89. PubMed ID: 28898679
[TBL] [Abstract][Full Text] [Related]
8. Advances in immune-based therapies of renal cell carcinoma.
Lam JS; Belldegrun AS; Figlin RA
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1081-96. PubMed ID: 15606335
[TBL] [Abstract][Full Text] [Related]
9. Novel targets and therapies for metastatic renal cell carcinoma.
Feldman DR; Motzer RJ
Oncology (Williston Park); 2006 Dec; 20(14):1745-53; discussion 1756. PubMed ID: 17263126
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib for the treatment of metastatic renal cell carcinoma.
Pick AM; Nystrom KK
Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
[TBL] [Abstract][Full Text] [Related]
11. [Biomarkers of response to molecular targeted therapy in renal cell carcinoma].
Mizuno R; Oya M
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1088-91. PubMed ID: 21772092
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma: molecular biology and targeted therapy.
Su D; Stamatakis L; Singer EA; Srinivasan R
Curr Opin Oncol; 2014 May; 26(3):321-7. PubMed ID: 24675233
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experience.
Procopio G; Verzoni E; Iacovelli R; Guadalupi V; Gelsomino F; Buzzoni R
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1631-40. PubMed ID: 22050012
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.
Shek D; Tomlinson B; Brown M; Brunson A; Pan CX; Lara PN
Clin Genitourin Cancer; 2012 Jun; 10(2):93-8. PubMed ID: 22382008
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of renal cell cancer.
Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutic approaches in renal cell carcinoma.
Parekh H; Rini BI
Expert Rev Anticancer Ther; 2015; 15(11):1305-14. PubMed ID: 26376584
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium.
Fay AP; Xie WL; Lee JL; Harshman LC; Bjarnason GA; Knox JJ; Ernst S; Wood L; Vaishamayan UN; Yuasa T; Tan MH; Rha SY; Donskov F; Agarwal N; Kollmannsberger CK; North SA; Rini BI; Choueiri TK; Heng DY
Clin Genitourin Cancer; 2015 Apr; 13(2):150-5. PubMed ID: 25458371
[TBL] [Abstract][Full Text] [Related]
18. Molecular targeted therapies for renal cell carcinoma.
Graham SD; Warden ME; Lou J
Can J Urol; 2007 Dec; 14 Suppl 1():48-52. PubMed ID: 18163945
[TBL] [Abstract][Full Text] [Related]
19. Cytokine therapy: a standard of care for metastatic renal cell carcinoma?
Hutson TE; Quinn DI
Clin Genitourin Cancer; 2005 Dec; 4(3):181-6. PubMed ID: 16425986
[TBL] [Abstract][Full Text] [Related]
20. [Renal cell carcinoma: Drug therapy and prognostic models].
Reiter MA; Kurosch M; Haferkamp A
Urologe A; 2015 May; 54(5):735-46; quiz 747-8. PubMed ID: 25987339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]